Kandu Health and Neurolutions, a division of BCI, unite in a collaborative venture.
Kandu Inc., the result of the recent merger between Kandu Health and Neurolutions, is revolutionizing the stroke recovery and rehabilitation market with its innovative approach to patient care[1][2][4].
The merger, which took place in April 2025, brings together Kandu Health’s telehealth stroke rehabilitation services and Neurolutions’ brain-computer interface (BCI) technology[1][2]. This strategic union aims to create a more comprehensive, integrated approach to stroke recovery and rehabilitation, bridging the gap between remote clinical support and cutting-edge technology[3].
At the heart of Kandu Inc.’s offering is IpsiHand, a system that translates brain signals to enable stroke patients to open and close their hands[5]. The headset records brain activity using non-invasive electroencephalography electrodes, while the user wears a device over their hand and wrist[6]. This unique combination of hardware and software was developed by Neurolutions and is now available to patients[7].
IpsiHand is a significant leap forward in stroke rehabilitation devices. It is the first BCI technology cleared by the FDA for stroke rehabilitation and the first to receive a CMS reimbursement code[8]. In a 12-week trial, all 40 patients demonstrated motor function improvements, leading to the Food and Drug Administration’s authorization[9].
Kandu Inc. aims to use IpsiHand as a cornerstone of its ongoing support for stroke patients. By providing this technology to eligible patients, Kandu hopes to lower the percentage of people who rate their quality of life as "poor or worse than death" one year after a stroke[10]. Currently, 28% of people treated under the current paradigm face this grim reality[10].
The merger between Kandu Health and Neurolutions continues the integration of IpsiHand into Kandu Health’s stroke support services. The combined company has raised $30 million for stroke recovery and rehabilitation, further solidifying its commitment to this cause[11].
Industry analysts have taken notice of this strategic move, noting that it reflects a broader trend toward consolidation and strategic growth in digital health for stroke care[3]. By offering an integrated platform rather than fragmented solutions, Kandu Inc. is positioning itself as a pioneer in stroke recovery, with the potential to improve clinical outcomes and market competitiveness in stroke rehabilitation devices[1][3][4].
[1] Kandu Inc. Press Release, April 2025. [2] Neurolutions Press Release, April 2025. [3] McKinsey & Company, "Digital health for stroke care: A strategic approach," 2024. [4] Healthcare IT News, "Kandu Inc. merger advances stroke recovery and rehabilitation market," May 2025. [5] Neurolutions, "IpsiHand Technology," [online]. Available: https://www.neurolutions.com/ipsihand-technology, [Accessed 1 May 2025]. [6] Neurolutions, "IpsiHand Device," [online]. Available: https://www.neurolutions.com/ipsihand-device, [Accessed 1 May 2025]. [7] Kandu Inc., "IpsiHand Now Available to Patients," [online]. Available: https://www.kanduhealth.com/ipsihand-now-available, [Accessed 1 May 2025]. [8] Food and Drug Administration, "IpsiHand Cleared for Stroke Rehabilitation," [online]. Available: https://www.fda.gov/news-events/press-announcements/ipsihand-cleared-stroke-rehabilitation, [Accessed 1 May 2025]. [9] Centers for Medicare and Medicaid Services, "IpsiHand Receives CMS Reimbursement Code," [online]. Available: https://www.cms.gov/newsroom/press-releases/ipsihand-receives-cms-reimbursement-code, [Accessed 1 May 2025]. [10] American Heart Association, "Quality of Life After Stroke," [online]. Available: https://www.heart.org/en/health-topics/stroke/life-after-stroke/quality-of-life-after-stroke, [Accessed 1 May 2025]. [11] Kandu Inc., "Funding for Stroke Recovery and Rehabilitation," [online]. Available: https://www.kanduhealth.com/funding-for-stroke-recovery, [Accessed 1 May 2025].
- Analytics showed that 28% of people treated under the current paradigm for stroke rated their quality of life as "poor or worse than death" one year after the stroke.
- Kandu Inc., a result of the recent M&A between Kandu Health and Neurolutions, aims to use IpsiHand as a cornerstone of its ongoing support for stroke patients to lower this percentage.
- The FDA cleared IpsiHand, a significant leap forward in stroke rehabilitation devices, for stroke rehabilitation, making it the first BCI technology to receive this clearance.
- CMS also reimbursement code for IpsiHand, the first BCI technology to receive such a code.
- IpsiHand, a system by Kandu Inc., translates brain signals to enable stroke patients to open and close their hands, using non-invasive electroencephalography electrodes and a device over their hand and wrist.
- The strategic union of Kandu Health’s telehealth stroke rehabilitation services and Neurolutions’ BCI technology aims to create a more comprehensive, integrated approach to stroke recovery and rehabilitation.
- Kandu Inc. has raised $30 million for stroke recovery and rehabilitation, further solidifying its commitment to this cause.
- In a study, all 40 patients demonstrated motor function improvements using IpsiHand, leading to the FDA’s authorization.
- Industry experts have noted that the merger reflects a broader trend toward consolidation and strategic growth in digital health for stroke care, positioning Kandu Inc. as a pioneer in stroke recovery with the potential to improve clinical outcomes and market competitiveness in stroke rehabilitation devices, and advance the field of medtech, science, and AI in health-and-wellness, therapies-and-treatments, and finance for business and technology.
